Reply on "teriparatide treatment for postmenopausal women with sacral insufficiency fracture".
作者信息
Yang Yao-Chun, Hsieh Min-Hong, Chien Jui-Teng, Liu Keng-Chang, Yang Chang-Chen
机构信息
National Taiwan University School of Medicine, Taiwan.
Department of Orthopedics, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi, 62247, Taiwan.
出版信息
Osteoporos Sarcopenia. 2023 Jun;9(2):77. doi: 10.1016/j.afos.2023.05.004. Epub 2023 Jun 17.
Abstract
摘要
相似文献
1
Reply on "teriparatide treatment for postmenopausal women with sacral insufficiency fracture".关于“特立帕肽治疗绝经后妇女骶骨不全骨折”的回复
Osteoporos Sarcopenia. 2023 Jun;9(2):77. doi: 10.1016/j.afos.2023.05.004. Epub 2023 Jun 17.
2
Teriparatide treatment shows faster healing than sacroplasty for postmenopausal women with sacral insufficiency fracture.对于患有骶骨不全骨折的绝经后女性，特立帕肽治疗比骶骨成形术愈合更快。
Osteoporos Sarcopenia. 2023 Mar;9(1):27-31. doi: 10.1016/j.afos.2023.02.001. Epub 2023 Feb 15.
3
Teriparatide treatment for postmenopausal women with sacral insufficiency fracture.特立帕肽治疗绝经后女性骶骨不全骨折
Osteoporos Sarcopenia. 2023 Jun;9(2):76. doi: 10.1016/j.afos.2023.05.003. Epub 2023 Jun 23.
4
Teriparatide Treatment in Elderly Patients With Sacral Insufficiency Fracture.特立帕肽治疗老年骶骨不全性骨折患者
J Clin Endocrinol Metab. 2017 Feb 1;102(2):560-565. doi: 10.1210/jc.2016-3582.
5
[Teriparatide as a therapy approach in sacral insufficiency fractures].[特立帕肽作为骶骨不全骨折的一种治疗方法]
Unfallchirurg. 2017 Nov;120(11):1000-1003. doi: 10.1007/s00113-017-0400-8.
6
Enhanced bone healing and decreased pain in sacral insufficiency fractures after teriparatide treatment: retrospective clinical-based observational study.特立帕肽治疗后骶骨不全骨折的骨愈合增强及疼痛减轻：基于临床的回顾性观察研究
Clin Cases Miner Bone Metab. 2017 May-Aug;14(2):140-145. doi: 10.11138/ccmbm/2017.14.1.140. Epub 2017 Oct 25.
7
Teriparatide and raloxifene reduce the risk of new adjacent vertebral fractures in postmenopausal women with osteoporosis. Results from two randomized controlled trials.特立帕肽和雷洛昔芬可降低绝经后骨质疏松症女性发生新的相邻椎体骨折的风险。两项随机对照试验的结果。
J Bone Joint Surg Am. 2009 Jun;91(6):1329-38. doi: 10.2106/JBJS.H.01030.
8
Sustained vertebral fracture risk reduction after withdrawal of teriparatide in postmenopausal women with osteoporosis.绝经后骨质疏松症女性停用特立帕肽后持续降低椎体骨折风险
Arch Intern Med. 2004 Oct 11;164(18):2024-30. doi: 10.1001/archinte.164.18.2024.
9
Cost-effectiveness of romosozumab for the treatment of postmenopausal women with osteoporosis at high risk of fracture in Belgium.罗莫佐单抗治疗绝经后骨质疏松症高骨折风险女性的成本效益：比利时研究
Osteoporos Int. 2024 Jul;35(7):1173-1183. doi: 10.1007/s00198-024-07043-2. Epub 2024 Apr 2.
10
The Fracture Incidence and Safety of Teriparatide and Bisphosphonate in Postmenopausal Women With Osteoporosis: A Meta-Analysis.绝经后骨质疏松症女性使用特立帕肽和双膦酸盐的骨折发生率和安全性：一项荟萃分析。
Altern Ther Health Med. 2024 Aug;30(8):258-263.
本文引用的文献
1
Teriparatide treatment for postmenopausal women with sacral insufficiency fracture.特立帕肽治疗绝经后女性骶骨不全骨折
Osteoporos Sarcopenia. 2023 Jun;9(2):76. doi: 10.1016/j.afos.2023.05.003. Epub 2023 Jun 23.
2
3
Effects of Percutaneous Sacroplasty on Pain and Mobility in Sacral Insufficiency Fracture.经皮骶骨成形术对骶骨不全骨折疼痛和活动能力的影响。
J Korean Neurosurg Soc. 2017 Jan 1;60(1):60-66. doi: 10.3340/jkns.2016.0505.010. Epub 2016 Dec 29.
4
Complications related to cement leakage in sacroplasty.椎体成形术中与骨水泥渗漏相关的并发症。
Acta Orthop Belg. 2012 Feb;78(1):100-5.
5
Teriparatide improves early callus formation in distal radial fractures.特立帕肽可促进桡骨远端骨折早期骨痂形成。
Acta Orthop. 2010 Apr;81(2):234-6. doi: 10.3109/17453671003761946.
6
Intermittent parathyroid hormone (PTH) treatment and age-dependent effects on rat cancellous bone and mineral metabolism.间歇性甲状旁腺激素（PTH）治疗及年龄依赖性对大鼠松质骨和矿物质代谢的影响。
J Orthop Res. 2007 Nov;25(11):1454-64. doi: 10.1002/jor.20433.
7
Human parathyroid hormone (1-34) accelerates natural fracture healing process in the femoral osteotomy model of cynomolgus monkeys.人甲状旁腺激素（1-34）可加速食蟹猴股骨截骨模型中的自然骨折愈合过程。
Bone. 2007 Jun;40(6):1475-82. doi: 10.1016/j.bone.2007.01.015. Epub 2007 Feb 2.
Zotero 插件